Personalized genetic prediction: too limited, too expensive, or too soon?

Editorial

John P A Ioannidis. Ann Intern Med. 2009.

. 2009 Jan 20;150(2):139-41.

doi: 10.7326/0003-4819-150-2-200901200-00012.

No abstract available

Comment on

Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3.
Paynter NP, Chasman DI, Buring JE, Shiffman D, Cook NR, Ridker PM. Paynter NP, et al. Ann Intern Med. 2009 Jan 20;150(2):65-72. doi: 10.7326/0003-4819-150-2-200901200-00003. Ann Intern Med. 2009. PMID: 19153409 Free PMC article.
Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation.
Eckman MH, Rosand J, Greenberg SM, Gage BF. Eckman MH, et al. Ann Intern Med. 2009 Jan 20;150(2):73-83. doi: 10.7326/0003-4819-150-2-200901200-00005. Ann Intern Med. 2009. PMID: 19153410